NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 238 filers reported holding NEOGENOMICS INC in Q1 2019. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $263,159 | -32.3% | 21,395 | -11.6% | 0.00% | -50.0% |
Q2 2023 | $388,910 | +15.1% | 24,201 | +245.8% | 0.00% | 0.0% |
Q3 2021 | $338,000 | +7.0% | 6,998 | 0.0% | 0.00% | +100.0% |
Q2 2021 | $316,000 | -62.2% | 6,998 | -59.6% | 0.00% | -75.0% |
Q1 2021 | $836,000 | -76.4% | 17,328 | -73.7% | 0.00% | -73.3% |
Q4 2020 | $3,548,000 | +29.2% | 65,899 | -11.5% | 0.02% | +15.4% |
Q3 2020 | $2,746,000 | +13.1% | 74,439 | -5.1% | 0.01% | +8.3% |
Q2 2020 | $2,429,000 | +8.0% | 78,399 | -3.8% | 0.01% | -14.3% |
Q1 2020 | $2,249,000 | -13.3% | 81,474 | -8.2% | 0.01% | +7.7% |
Q4 2019 | $2,595,000 | +3.1% | 88,729 | -32.6% | 0.01% | -7.1% |
Q3 2019 | $2,518,000 | -13.7% | 131,671 | -1.0% | 0.01% | -12.5% |
Q2 2019 | $2,917,000 | +331.5% | 132,946 | +302.6% | 0.02% | +300.0% |
Q1 2019 | $676,000 | -16.4% | 33,019 | -48.5% | 0.00% | -20.0% |
Q4 2018 | $809,000 | +6.0% | 64,134 | +29.0% | 0.01% | +25.0% |
Q3 2018 | $763,000 | – | 49,729 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |